QIAGEN Hit with Preliminary Injunction Against US Sales of NGS System

/0 Comments/in , /by

Venlo, the Netherlands and Hilden, Germany 9/10/16; San Francisco, CA 9/9/16–The US District Court for the Northern District of California has granted Illumina’s motion for a preliminary injunction barring the sale of QIAGEN’s GeneReader NGS System and related products in the US. The ruling stems from a patent infringement suit brought in May by Illumina […]

Read more →

Danaher Buys Cepheid for $4 Billion

/0 Comments/in , /by

Washington, DC 9/6/16; Sunnyvale, CA 9/6/16–Technology provider Danaher has agreed to acquire publicly held Cepheid, a supplier of molecular diagnostics system, for $4 billion, including debt and net of acquired cash. This is equal to $53 per share in cash, a 54% premium to Cepheid’s closing price on September 2. Cepheid’s 2015 revenue totaled $539 […]

Read more →